CUBE vs MXCT · P/E 25, rev $1.07B vs rev $38.6M
CubeSmart (CUBE) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the CUBE and MXCT stock pages for the full models.
Not investment advice.